跳至主要内容
临床试验/NCT07268937
NCT07268937
已完成
不适用

Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices

Fondazione IRCCS Policlinico San Matteo di Pavia1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2023年7月6日最近更新:

概览

阶段
不适用
状态
已完成
发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
入组人数
25
试验地点
1
主要终点
Comparison of the results relating to the degree of steatosis detected by the various ultrasound devices with the CAP module

概览

简要总结

Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease, with an estimated prevalence of 5-30% in the general population and 55-80% in patients with type 2 diabetes.

Methods for the quantitative and non-invasive assessment of liver fat content have recently been implemented on ultrasound devices, based on the estimation of the ultrasound beam attenuation coefficient and backscattering. These methods are CE marked and already commercially available.

The aim of the study is to compare the results of the degree of steatosis detected by different ultrasound devices with the degree of steatosis of the CAP (Controlled Attenuation Parameter) module implemented on the Fibroscan machine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age \> 18 years,
  • ability to hold breath for image acquisition,
  • informed consent

排除标准

  • withdrawal of informed consent,
  • any condition which, in the clinical judgement of the investigator, will make further participation in the study unacceptable for that individual patient

结局指标

主要结局

Comparison of the results relating to the degree of steatosis detected by the various ultrasound devices with the CAP module

时间窗: 05 May 2025

次要结局

未报告次要终点

研究者

发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gianluigi Poma

Principal Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

研究点 (1)

Loading locations...

相似试验